WHO ICTRP trial

Standardised Early Palliative Care For Patients With Aggressive Haematological…

ACTRN12624001173583 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12624001173583
Public title Standardised Early Palliative Care For Patients With Aggressive Haematological Malignancies
Scientific title Acceptability of Standardised Early Palliative Care For Patients With Aggressive Haematological Malignancies
Primary sponsor Austin Health
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries Australia
Conditions Acute Leukaemia;Aggressive Lymphoma;Myeloma;Steroid refractory Graft Versus Host Disease; Acute Leukaemia Aggressive Lymphoma Myeloma Steroid refractory Graft Versus Host Disease;Cancer - Leukaemia - Acute leukaemia;Cancer - Lymphoma (non…
Interventions Education on the rationale for and design of the study will be provided to the haematology department at Austin Health. This will be provided as a single one hour online session delivered by a palliative care physician in which the project…
Registration date Sep 25, 2024
Target size 25
Secondary IDs Nil
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations